Variable | Enterobacter SBP (n = 32) | E. coli SBP (n = 128) | P |
---|---|---|---|
Male sex | 26 (81.3) | 104 (81.3) | Â |
Age, years (mean ± SD) | 55 ± 10.9 | 55 ± 11.7 |  |
SBP subtype | Â | Â | 0.03 |
 Definite SBPa | 26 (81.2) | 78 (60.9) |  |
 Probable SBPb | 6 (18.8) | 50 (39.1) |  |
Place of acquisition | Â | Â | <0.001 |
 Community | 12 (37.5) | 98 (76.6) |  |
 Hospital | 20 (62.5) | 30 (23.4) |  |
Concomitant hepatocellular carcinoma | 21 (65.6) | 48 (37.5) | 0.004 |
Causes of liver cirrhosis | Â | Â | 0.79 |
 Hepatitis B virus | 21 (65.6) | 88 (68.8) |  |
 Hepatitis C virus | 2 (6.2) | 13 (10.2) |  |
 Alcoholism | 6 (18.8) | 19 (14.8) |  |
 Others | 3 (9.4) | 8 (6.2) |  |
Child-Pugh class | Â | Â | 0.006 |
 A | 1 (3.1) | 0 (0) |  |
 B | 10 (31.3) | 17 (13.3) |  |
 C | 21 (65.6) | 111 (86.7) |  |
MELD score, median (IQR) | 19 (15–24) | 23 (18–29) | 0.03 |
Underlying diseases | Â | Â | Â |
 Diabetes mellitus | 9 (28.1) | 25 (19.5) | 0.29 |
 Alcoholism | 6 (18.8) | 23 (18.0) | 0.92 |
 Solid cancer (other than hepatoma) | 3 (9.4) | 4 (3.1) | 0.14 |
 Chronic kidney disease | 1 (3.1) | 2 (1.6) | 0.49 |
 Solid organ transplantation | 1 (3.1) | 0 (0) | 0.20 |
Comorbid conditions | Â | Â | Â |
 Transarterial chemoembolization (<30 days) | 4 (12.5) | 4 (3.1) | 0.052 |
 Endoscopic intervention (≤30 days) | 8 (25.0) | 7 (5.5) | 0.001 |
 Varix control | 5 | 6 |  |
 ERCP | 3 | 1 |  |
Systemic anticancer chemotherapy (≤30 days) | 3 (9.4) | 0 (0) | 0.007 |
Prior hospitalization (≤90 days) | 26 (81.2) | 74 (57.8) | 0.01 |
Prior antimicrobial therapy (<30Â days) | 19 (59.4) | 36 (28.1) | 0.001 |